Synonyms: FHD286
Comment: FHD-286 is a first-in-class oral allosteric BAF complex inhibitor. It targets the SMARCA4 (BRG1) subunit of the complex. FHD-286 was developed by Foghorn Therapeutics, and its chemical structure was disclosed at the AACR spring meeting in 2022.
|
|
2D Structure
|
|
Physico-chemical Properties
|
|
Hydrogen bond acceptors
|
11
|
Hydrogen bond donors
|
2
|
Rotatable bonds
|
11
|
Topological polar surface area
|
181.37
|
Molecular weight
|
562.17
|
XLogP
|
1.94
|
No. Lipinski's rules broken
|
1
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
SMILES / InChI / InChIKey
|
|
Canonical SMILES
|
COC[C@@H](C(=O)Nc1scc(n1)c1cccc(n1)N1C[C@H](C)O[C@@H](C1)C)NC(=O)c1ccn(c1)S(=O)(=O)C
|
Isomeric SMILES
|
COC[C@H](NC(=O)c1cn(cc1)S(=O)(=O)C)C(=O)Nc1nc(cs1)c1cccc(n1)N1C[C@H](C)O[C@H](C)C1
|
InChI
|
InChI=1S/C24H30N6O6S2/c1-15-10-29(11-16(2)36-15)21-7-5-6-18(25-21)20-14-37-24(27-20)28-23(32)19(13-35-3)26-22(31)17-8-9-30(12-17)38(4,33)34/h5-9,12,14-16,19H,10-11,13H2,1-4H3,(H,26,31)(H,27,28,32)/t15-,16+,19-/m0/s1
|
InChI Key
|
JBLQNFBXKOAIHG-FCEWJHQRSA-N
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
|